You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-GFAP (phospho S38) antibody (ab62479)

Overview

  • Product nameAnti-GFAP (phospho S38) antibodySee all GFAP primary antibodies ...
  • Description
    Rabbit polyclonal to GFAP (phospho S38)
  • Specificityab62479 detects endogenous levels of GFAP only when phosphorylated at serine 38.
  • Tested applicationsELISA, IHC-P, IHC-Fr more details
  • Species reactivity
    Reacts with: Mouse, Human
  • Immunogen

    Synthetic phosphopeptide derived from human GFAP around the phosphorylation site of serine 38 (R-L-SP-L-A).

  • Positive controlHuman brain tissue.

Properties

Applications

Our Abpromise guarantee covers the use of ab62479 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
ELISA ELISA: 1/5000.
IHC-P IHC-P: 1/50 - 1/100.
IHC-Fr IHC-Fr: 1/100 - 1/200.

Target

  • FunctionGFAP, a class-III intermediate filament, is a cell-specific marker that, during the development of the central nervous system, distinguishes astrocytes from other glial cells.
  • Tissue specificityExpressed in cells lacking fibronectin.
  • Involvement in diseaseDefects in GFAP are a cause of Alexander disease (ALEXD) [MIM:203450]. Alexander disease is a rare disorder of the central nervous system. It is a progressive leukoencephalopathy whose hallmark is the widespread accumulation of Rosenthal fibers which are cytoplasmic inclusions in astrocytes. The most common form affects infants and young children, and is characterized by progressive failure of central myelination, usually leading to death usually within the first decade. Infants with Alexander disease develop a leukoencephalopathy with macrocephaly, seizures, and psychomotor retardation. Patients with juvenile or adult forms typically experience ataxia, bulbar signs and spasticity, and a more slowly progressive course.
  • Sequence similaritiesBelongs to the intermediate filament family.
  • Post-translational
    modifications
    Phosphorylated by PKN1.
  • Cellular localizationCytoplasm. Associated with intermediate filaments.
  • Target information above from: UniProt accession P14136 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links
  • Alternative names
      Astrocyte antibodyFLJ42474 antibodyFLJ45472 antibody
      GFAP antibodyGFAP_HUMAN antibodyGlial Fibrillary Acidic Protein antibodyIntermediate filament protein antibody
    see all

Anti-GFAP (phospho S38) antibody images

  • ab62479, at 1/50 dilution, staining GFAP in paraffin embedded human brain tissue by Immunohistochemsitry in the absence (left image) or presence (right image) of the immunising peptide.
  • ab62479 staining GFAP (phospho S38) in mouse brain tissue section by Immunohistochemistry (Frozen sections). Tissue samples were fixed with paraformaldehyde and blocking with a dilution buffer containing 2% Block Ace, 0.05% Triton X-100 and PBS was performed at 250C for 1 hour. The sample was incubated with primary antibody (1/100) at 40C for 12 hours. A Cyt3 ® -conjugated donkey polyclonal to rabbit IgG was used as secondary antibody at 1/500 dilution.

    See Abreview

References for Anti-GFAP (phospho S38) antibody (ab62479)

ab62479 has not yet been referenced specifically in any publications.

Product Wall

Filter by Application

Filter by Species

Filter by Ratings

Application Immunohistochemistry (Frozen sections)
Sample Mouse Tissue sections (brain)
Specification brain
Fixative Paraformaldehyde
Permeabilization Yes - 0.5%TritonX-100/PBS
Blocking step BSA as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 25°C
Username

Verified customer

Submitted Jul 13 2009

Application Immunohistochemistry (Frozen sections)
Sample Mouse Tissue sections (Brain)
Specification Brain
Fixative Paraformaldehyde
Permeabilization No
Blocking step (agent) for 1 hour(s) and 0 minute(s) · Concentration: 2% · Temperature: 25°C
Username

Verified customer

Submitted Jun 18 2009

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"